Biotech · Private company · New York, NY, US
Gilgamesh Pharmaceuticals Inc
Track this companyFree. Adds Gilgamesh Pharmaceuticals Inc to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards2
- Development of a Safer and More Effective Ibogaine Analog for the Treatment of Opioid Use DisorderFiscal year 2025 · $841.3KNIH RePORTER 5UG3DA060053-02 · fetched Nov 12, 2026
- Development of a Safer and More Effective Ibogaine Analog for the Treatment of Opioid Use DisorderFiscal year 2024 · $2.7MNIH RePORTER 1UG3DA060053-01 · fetched Nov 12, 2026